Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,121 | 84 | 97.2% |
| Education | $32.27 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $110.81 | 8 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $100.64 | 8 | $0 (2018) |
| Novo Nordisk Inc | $96.37 | 6 | $0 (2018) |
| Amgen Inc. | $96.35 | 6 | $0 (2018) |
| Lilly USA, LLC | $77.96 | 6 | $0 (2018) |
| Shire North American Group Inc | $73.39 | 4 | $0 (2018) |
| PFIZER INC. | $68.20 | 6 | $0 (2018) |
| GlaxoSmithKline, LLC. | $62.23 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $58.01 | 4 | $0 (2018) |
| Circassia Pharmaceuticals Inc | $44.89 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.01 | 1 | ABBVIE INC. ($16.01) |
| 2021 | $23.49 | 1 | AbbVie Inc. ($23.49) |
| 2018 | $586.41 | 43 | Shire North American Group Inc ($73.39) |
| 2017 | $527.82 | 40 | Novo Nordisk Inc ($57.98) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/18/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Diabetes | ||||||
| 11/27/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Neuroscience | ||||||
| 11/16/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Central Nervous System | ||||||
| 11/02/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Lower GI | ||||||
| 10/23/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/29/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes | ||||||
| 09/25/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/07/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Diabetes | ||||||
| 08/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 08/17/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 08/10/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, DULERA | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/27/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: DIABETES | ||||||
| 07/20/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Endocrinology | ||||||
| 07/10/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/02/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/29/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Pain Management | ||||||
| 06/22/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 487 | 719 | $116,795 | $57,785 |
| 2022 | 6 | 584 | 825 | $112,742 | $57,668 |
| 2021 | 9 | 693 | 959 | $123,813 | $69,044 |
| 2020 | 9 | 499 | 733 | $97,218 | $47,724 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 365 | $63,875 | $28,397 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 135 | 135 | $27,405 | $16,817 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 98 | $12,320 | $5,068 | 41.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $7,980 | $3,395 | 42.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 37 | $2,479 | $2,429 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,716 | $1,145 | 66.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $748.00 | $499.12 | 66.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 16 | $272.00 | $35.20 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 366 | $60,326 | $28,299 | 46.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 136 | 136 | $27,608 | $17,314 | 62.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 129 | $16,324 | $6,241 | 38.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 39 | 40 | $2,680 | $2,626 | 98.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 108 | 108 | $3,780 | $1,903 | 50.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 46 | $2,024 | $1,286 | 63.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 413 | $64,841 | $33,618 | 51.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 131 | 131 | $26,593 | $16,965 | 63.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 127 | $13,462 | $7,503 | 55.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 59 | 59 | $3,953 | $3,772 | 95.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 20 | 20 | $5,120 | $3,314 | 64.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 119 | 119 | $4,165 | $2,131 | 51.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 62 | 62 | $2,728 | $987.23 | 36.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,662 | $715.53 | 26.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 13 | 17 | $289.00 | $38.25 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 142 | 311 | $47,254 | $20,227 | 42.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 52 | 52 | $13,312 | $8,535 | 64.1% |
About Dr. Michael Chen, MD
Dr. Michael Chen, MD is a Family Medicine healthcare provider based in Streetsboro, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710182332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chen, MD has received a total of $1,154 in payments from pharmaceutical and medical device companies, with $16.01 received in 2024. These payments were reported across 85 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,121).
As a Medicare-enrolled provider, Chen has provided services to 2,263 Medicare beneficiaries, totaling 3,236 services with total Medicare billing of $232,222. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Streetsboro, OH
- Active Since 06/15/2007
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1710182332
Products in Payments
- MYDAYIS (Drug) $73.39
- JARDIANCE (Drug) $63.60
- Prolia (Biological) $62.74
- TRADJENTA (Drug) $53.79
- INVOKANA (Drug) $50.79
- XARELTO (Drug) $49.85
- FARXIGA (Drug) $47.25
- TUDORZA PRESSAIR (Drug) $44.89
- Trintellix (Drug) $40.03
- KYPHON Balloon Kyphoplasty (Device) $38.76
- ANORO (Drug) $34.79
- Tresiba (Drug) $32.27
- Mitigare (Drug) $30.69
- SPIRIVA RESPIMAT (Drug) $30.10
- Amitiza (Drug) $29.72
- Ozempic (Drug) $26.87
- Victoza (Drug) $25.27
- PREVNAR - 13 (Biological) $24.44
- TRULICITY (Drug) $24.17
- AVYCAZ (Drug) $23.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Streetsboro
Dr. Sarah Slater Lang, M.d, M.D
Family Medicine — Payments: $3,723
Sherri Barr, Md, MD
Family Medicine — Payments: $3,150
Dr. Hugh O'neill, Md, MD
Family Medicine — Payments: $895.23
Mrs. Isabelle Lane, D.o, D.O
Family Medicine — Payments: $362.09
Stephen Battles, D.o, D.O
Family Medicine — Payments: $111.83
Dominic Lefoer, M.d, M.D
Family Medicine — Payments: $108.19